Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 3,160,000 | 2,803,000 | 2,661,000 | 2,682,000 | 2,744,300 |
| Cost of Goods | 620,000 | 522,000 | 521,000 | 513,000 | 473,600 |
| Gross Profit | 2,540,000 | 2,281,000 | 2,140,000 | 2,169,000 | 2,124,399 |
| Operating Expenses | 2,015,000 | 1,446,000 | 1,505,000 | 1,360,000 | 1,723,600 |
| Operating Income | 525,000 | 835,000 | 635,000 | 809,000 | 547,700 |
| Interest Expense | 0 | 0 | 0 | 0 | -49,500 |
| Other Income | 204,000 | -86,000 | -61,000 | -57,000 | -31,200 |
| Pre-tax Income | 729,000 | 749,000 | 574,000 | 752,000 | 566,000 |
| Income Tax | 226,000 | 232,000 | 178,000 | 233,000 | 166,100 |
| Net Income Continuous | 504,000 | 514,000 | 394,000 | 517,200 | 405,600 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | 5,300 |
| Net Income | $504,000 | $514,000 | $394,000 | $517,200 | $410,900 |
| EPS Basic Total Ops | 0.13 | 0.13 | 0.10 | 0.14 | 0.11 |
| EPS Basic Continuous Ops | 0.13 | 0.13 | 0.10 | 0.14 | 0.11 |
| EPS Diluted Total Ops | 0.13 | 0.13 | 0.10 | 0.14 | 0.11 |
| EPS Diluted Continuous Ops | 0.13 | 0.13 | 0.10 | 0.14 | 0.11 |
| EBITDA(a) | $646,000 | $937,000 | $741,000 | $910,000 | $547,700 |